Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cassava Sciences Inc (SAVA)

45.88   0.19 (0.42%) 01-16 20:17
Open: 44.93 Pre. Close: 45.69
High: 46.43 Low: 44.1
Volume: 1,413,152 Market Cap: 1,836M
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 46.453 - 46.682 46.682 - 46.914
Low: 43.577 - 43.807 43.807 - 44.041
Close: 45.499 - 45.874 45.874 - 46.255

Technical analysis

as of: 2022-01-15 8:49:32 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 64.31     One year: 75.11
Support: Support1: 42.30    Support2: 34.41
Resistance: Resistance1: 55.06    Resistance2: 64.31
Pivot: 46.84
Moving Average: MA(5): 47.62     MA(20): 45.70
MA(100): 52.44     MA(250): 59.54
MACD: MACD(12,26): -0.37     Signal(9): -0.77
Stochastic oscillator: %K(14,3): 35.80     %D(3): 47.61
RSI: RSI(14): 46.52
52-week: High: 146.16  Low: 11.71  Change(%): 279.8
Average Vol(K): 3-Month: 483381  10-Days: 256448

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SAVA has closed above bottom band by 39.0%. Bollinger Bands are 75.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to SAVA's normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 12 Jan 2022
Biogen (BIIB) Down on Medicare Draft Ruling for Alzheimer's Drugs - Nasdaq

Fri, 31 Dec 2021
How Are The Shorts Feeling About Cassava Sciences Inc? - Benzinga - Benzinga

Thu, 30 Dec 2021
Cassava Sciences, Inc. - A Rational Expectation If All Goes Well With Simufilam - Seeking Alpha

Thu, 23 Dec 2021
February 2022 Options Now Available For Cassava Sciences (SAVA) - Nasdaq

Wed, 22 Dec 2021
BlackBerry, Tesla, Cassava Sciences, Paychex: What to Watch When the Stock Market Opens Today - The Wall Street Journal

Wed, 22 Dec 2021
(SAVA) - Analyzing Cassava Sciences Inc's Short Interest - Benzinga - Benzinga

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 40
Shares Float (M) 37
% Held by Insiders 6.39
% Held by Institutions 30.03
Shares Short (K) 8,380
Shares Short P. Month (K) 9,420

Stock Financials

EPS -0.560
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 6.690
Profit Margin
Operating Margin
Return on Assets (ttm) -8.8
Return on Equity (ttm) -14.3
Qtrly Rev. Growth
Gross Profit (p.s.) -0.076
Sales Per Share
EBITDA (p.s.) -0.520
Qtrly Earnings Growth
Operating Cash Flow (M) -23
Levered Free Cash Flow (M) -38

Stock Valuations

PE Ratio -81.93
PEG Ratio
Price to Book value 6.86
Price to Sales
Price to Cash Flow -78.53

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2017-05-09
Ex-Dividend Date 2012-12-12
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.